Aspirin and Extended-Release Dipyridamole
- Product NDC
- 62175-330
- 11-digit product format
- 621750330
- Labeler code
- 62175
- Product ID
- 62175-330_b4e7c369-7ea7-46e0-8282-a73a813d8421
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Aspirin and Extended-Release Dipyridamole
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Lannett Company, Inc.
- Application
- ANDA204552
- Marketing category
- ANDA
- Marketing start
- 2019-03-20
- Marketing end
- 0000-00-00
- Substance
- ASPIRIN; DIPYRIDAMOLE
- Active strength
- 25 mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Platelet Aggregation Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 62175-330-35 | 62175033035 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62175-330-35) | 2019-03-20 | 0000-00-00 | No | No | Current |